ArticleTranslational cancer research2020

IL-27/IL-27RA signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway.

Hua-Cheng Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.